81 related articles for article (PubMed ID: 90901)
21. Combined use of clomiphene and intranasal luteinizing hormone-releasing hormone for induction of ovulation in chronically anovulatory women.
Phansey SA; Barnes MA; Williamson HO; Sagel J; Nair RM
Fertil Steril; 1980 Nov; 34(5):448-51. PubMed ID: 7002630
[TBL] [Abstract][Full Text] [Related]
22. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
23. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
Balogh A; Ditrói F; Lampé LG
Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
[TBL] [Abstract][Full Text] [Related]
24. [Doses-related effects of lynestrenol on ovulation (author's transl)].
Pizarro MA; Thomas K; Ferin J
Reproduccion; 1976; 3(3-4):193-205. PubMed ID: 802117
[TBL] [Abstract][Full Text] [Related]
25. Luteinizing hormone-releasing hormone (LHRH) and its analogs for contraception in women: a review.
Thau RB
Contraception; 1984 Feb; 29(2):143-62. PubMed ID: 6426857
[TBL] [Abstract][Full Text] [Related]
26. Intranasal gonadotropin-releasing hormone agonist as a contraceptive agent.
Bergquist C; Nillius SJ; Wide L
Lancet; 1979 Aug; 2(8136):215-7. PubMed ID: 89330
[TBL] [Abstract][Full Text] [Related]
27. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
Lasley BL; Wang CF; Yen SS
J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
[TBL] [Abstract][Full Text] [Related]
28. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
29. Current status of antagonistic analogs of LH-RH as a contraceptive method in the female.
Schally AV
Res Front Fertil Regul; 1983 Jul; 2(5):1-16. PubMed ID: 12179624
[TBL] [Abstract][Full Text] [Related]
30. Gonadotropin releasing hormone analogs for female contraception by inhibition of ovulation.
Nillius SJ
J Steroid Biochem; 1985 Nov; 23(5B):849-54. PubMed ID: 2934581
[TBL] [Abstract][Full Text] [Related]
31. Luteinizing hormone releasing hormone analogues for contraception.
Nillius SJ
Clin Obstet Gynaecol; 1984 Dec; 11(3):551-72. PubMed ID: 6391776
[TBL] [Abstract][Full Text] [Related]
32. Action of luteinizing hormone-releasing factor (lrf) in the initiation of lordosis behavior in the estrone-primed ovariectomized female rat.
Moss RL; McCann SM
Neuroendocrinology; 1975; 17(4):309-18. PubMed ID: 806824
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of the postcoital contraceptive effect of LH-RH in the rat. I. Serum hormone levels during chronic LH-RH Administration.
Beattie CW; Corbin A; Cole G; Corry S; Jones RC; Koch K; Tracy J
Biol Reprod; 1977 Apr; 16(3):322-32. PubMed ID: 321040
[TBL] [Abstract][Full Text] [Related]
35. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle.
Saunders DM; Marcus SL; Saxena BB; Beling CG; Connell EB
Fertil Steril; 1971 May; 22(5):332-44. PubMed ID: 4102481
[TBL] [Abstract][Full Text] [Related]
36. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
37. Novel peptides in ovarian follicular fluid: implications for contraceptive development.
Schwartz NB
Res Front Fertil Regul; 1982 Sep; 2(2):1-11. PubMed ID: 12179632
[TBL] [Abstract][Full Text] [Related]
38. Clinical applications of LHRH and its analogues.
Sandow J
Clin Endocrinol (Oxf); 1983 Jun; 18(6):571-92. PubMed ID: 6136347
[TBL] [Abstract][Full Text] [Related]
39. Anovulatory effect of a LHRH antagonist in women.
Zarate A; Canales ES; Sthory I; Coy DH; Comaru-Schally AM; Schally AV
Contraception; 1981 Sep; 24(3):315-20. PubMed ID: 7030615
[TBL] [Abstract][Full Text] [Related]
40. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
